Publication | Open Access

Part 1: Structure–Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38α mitogen-activated protein kinase

Structure–activity RelationshipPart 1Drug TargetBiochemistryMedicineRational Drug DesignPharmacological AgentFused PyrazolesPharmacologyDrug Discovery